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The Year in Cardiac Imaging
Raymond J. Gibbons, MD,* Philip A. Araoz, MD,y Thomas C. Gerber, MD, PHD*y
Rochester, MinnesotaThis review is a sequel to our 8 previous reports summa-
rizing the most important published research for single-
photon emission computed tomography (SPECT), cardiac
positron emission tomography (PET), cardiac computed
tomography (CT), and cardiac magnetic resonance imaging
(MRI). This report generally covers the English-language
published data between July 1, 2011, and September 30,
2012.
We have again organized our summary around topical
themes in the belief that an integrated, multi-modality
imaging approach is ideal for the solution of most clinical
problems.Technical Developments
PET/CT. Plaque biology remains of great interest.
Dweck et al. (1) reported the use of combined PET and
CT to investigate uptake of ﬂuorine-18-sodium ﬂuoride
(18F-NaF) as a marker of plaque calciﬁcation and ﬂuorine-
18-ﬂuorodeoxyglucose (FDG) as a marker of plaque
inﬂammation. They found that, in 119 volunteers, 18F-NaF
uptake was higher in patients with coronary atherosclerosis
and correlated (r ¼ 0.65) with the calcium score, although
40% of patients with very high calcium scores (>1,000) had
normal uptake. In contrast, FDG uptake in the coronary
arteries was confounded by myocardial activity and not
increased in patients with atherosclerosis.
In a second study on the same patients, Dweck et al. (2)
reported the use of 18F-NaF and FDG to examine calciﬁ-
cation and inﬂammation in aortic valve disease. Patients
with aortic stenosis had higher activity of both tracers than
control subjects. The 18F-NaF uptake increased with valve
severity (R2 ¼ 0.54) and had a much closer relationship than
FDG (R2 ¼ 0.22). Of patients with aortic stenosis, 91% had
increased 18F-NaF uptake; only 35% had increased FDG
uptake. As noted by Aikawa and Otto (3), many more
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future drug trials.
Patient Safety
Cardiac CT radiation dose reduction. Efforts at balancing
radiation dose and image quality in CT continue. Radiation
dose varies exponentially with changes of the tube potential,
but so does image noise. The decision to use tube voltage
of 100 kVp versus 120 kVp is sometimes based on body
mass index (BMI). However, BMI often reﬂects abdominal
thickness more than chest thickness. In a series of
106 consecutive cardiac CT angiograms, acquired at 120 kVp
(n ¼ 64) or 100 kVp (n ¼ 42), Ghafourian et al. (4) deter-
mined both subjective and objective measures of image quality
and compared these measures with both BMI and scout view
attenuation. Scout view attenuation was the best predictor of
image noise and “low noise” images (area under the curve,
0.73). After adjustment for the scout view attenuation, BMI
was not statistically signiﬁcant. This suggests that the scout
view can help decide which tube potential to use.
The ﬁndings of prospective, randomized studies of
image quality and radiation exposure including more than
100 patients are summarized in Table 1 (5,6).
Diagnosis: Coronary Artery Disease
CT: coronary stenoses. With the maturation of technical
aspects of coronary computed tomography angiography
(CTA), the research focus is increasingly shifting toward
identifying the patient groups in which coronary CTA
provides the most value.
In a retrospective analysis of 14,048 patients enrolled in
the CONFIRM (Coronary CT Angiography Evaluation for
Clinical Outcomes: An International Multicenter Registry)
(7), pre-test probability was estimated on the basis of sex,
age, and chest pain. The observed prevalences for 50% and
70% diameter coronary stenoses on coronary CTA were
substantially lower than those predicted by clinical parame-
ters (18% vs. 51% for>50% stenoses, 10% vs. 42% for>70%
stenoses; p < 0.001), particularly for patients with typical
angina (19% vs. 71% for >70% stenosis) (Fig. 1). In an
accompanying editorial, Diamond (8) attributed some of
these differences to the use of self-administered question-
naires and veriﬁcation bias.
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2472The high negative predictive value (NPV) of coronaryCTA
is important for its use to “rule out” coronary artery disease
(CAD). Most of the studies showing this high NPV were
performed in populations with low to intermediate pre-test
probability. In a retrospective analysis of prospectively
acquired data for the CORE-64 study (Coronary Artery
Evaluation Using 64-Row Multi-Detector Computed To-
mography Angiography), Arbab-Zadeh et al. (9) examined
the impact of disease prevalence and coronary calcium on the
diagnostic accuracy of coronary CTA. Although the areas
under the curve for diagnostic accuracy were similar for
patients with intermediate probability of CAD, high proba-
bility for CAD, and known CAD (0.93, 0.92, and 0.93,
respectively), the NPVs varied substantially (0.90, 0.83, and
0.50, respectively [p< 0.001]) and decreased to 0.81when the
calcium score was600. In patients with high calcium scores
and high pre-test probability for obstructive CAD, the NPV
of coronary CTA is lower than previously reported.
Population radiation exposure can be potentially reduced
by prospectively identifying patients who are likely to have
nondiagnostic image quality of coronary CTA. In a retro-
spective analysis of registry data, Vanhecke et al. (10)
developed an “uninterpretable risk score” in 8,585 symp-
tomatic patients and used it to predict uninterpretable
studies in 915 subsequent symptomatic patients. For each 4-
point increase of the score (maximum, 32 points), the rate of
encountering at least 1 uninterpretable coronary segment
increased approximately 1.5-fold. Increased heart rate and
the coronary calcium score were most predictive of unin-
terpretable coronary CTA results. Patients with an unin-
terpretable study had an increased frequency of adverse
outcomes over 3-month follow-up.
CT myocardial perfusion imaging. The technology and
application of computed tomography myocardial perfusion
imaging (CTMPI) continue to evolve.
Ko et al. (11) compared invasive fractional ﬂow reserve
(FFR) measurements and adenosine stress CTMPI in 86
coronary perfusion territories that were supplied by vessels
with 50% diameter stenosis. Blinded qualitative assess-
ment of segmental CTMPI after triphasic injection of
contrast during adenosine infusion correctly identiﬁed 31 of
41 (76%) territories with FFR 0.8 (Fig. 2). The CTMPI
was normal in 38 of 45 (84%) myocardial segments with
preserved FFR. The combination of a defect on CTMPI
and a 50% stenosis on coronary CTA (with 320 detector
rows) was 98% speciﬁc for identifying abnormal FFR, and
the combination of normal CTMPI and a stenosis <50% or
less on coronary CTA was 100% speciﬁc for identifying
preserved FFR (Fig. 2).
Computational ﬂuid dynamics can be applied to estimate
FFR from typical coronary CTA protocols, which currently
requires proprietary software and approximately 5 h/exam.
Koo et al. (12) compared FFR by CT with invasive FFR in
159 vessels of 103 patients (Fig. 3). The accuracy of
abnormal FFR by CT to identify vessels with abnormal
invasive FFR (0.8) was 84.3%. The FFR by CT correlated
Figure 1 Prevalence of Coronary Artery Diameter Stenoses
Prevalence of coronary artery diameter stenoses (50%) as observed (solid bars)
on computed tomography angiography and as expected (open bars) on the basis
of clinical criteria in patients with varying presentations, stratiﬁed by age. The
numbers above note the observed/expected ratio of coronary artery stenosis
prevalence. This ratio is increased with age in men with atypical angina
(p < 0.001) and typical angina (p < 0.001) but not in women. CAD ¼ coronary
artery disease. Reprinted, with permission, from Cheng et al. (7).
Figure 2
FFR Compared With Combinations of
Coronary CTA and CT Myocardial Perfusion Imaging
Fractional ﬂow reserve (FFR) compared with combinations of coronary computed
tomography angiography (CTA) and computed tomography (CT) myocardial
perfusion imaging ﬁndings in 86 myocardial perfusion territories. The FFR is lowest
in patients who have both stenosis 50% on coronary CTA and myocardial
perfusion abnormalities and highest in patients with no signiﬁcant stenosis and
no myocardial perfusion defects. Among patients with discrepant results, FFR
correlates better with myocardial perfusion abnormalities then with angiographic
stenosis. CTA 50 ¼ diameter stenosis 50% on coronary CTA; CTA <50 ¼
diameter stenosis <50% on CTA; CTP þve ¼ CT abnormal myocardial perfusion by
CT; CTP ve ¼ normal myocardial perfusion by CT. Reprinted, with permission,
from Ko et al. (11).
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2473well with invasive FFR (r ¼ 0.717, p < 0.001) with a slight
underestimation (0.022  0.116, p ¼ 0.016).
MRI and SPECT. In a cardiac MRI examination,
multiple parameters can be measured, each of which can
separately be used to detect CAD. However, there have been
no prospective studies comparing a multiparametric cardiac
MRI approach with SPECT for the detection of CAD. In
a prospective study (Clinical Evaluation of MAgnetic
Resonance imaging in Coronary heart disease) performed by
Greenwood et al. (13), 628 patients with angina underwent
a multiparametric cardiac MRI examination, stress SPECT,
and subsequent invasive angiography.
The cardiac MRI protocol included rest and adenosine
stress perfusion, resting wall motion assessment, delayed
enhancement, and coronary magnetic resonance angiog-
raphy. The cardiac MRI ﬁndings suggesting ﬂow-limiting
stenoses (change in perfusion from rest to stress) or
myocardial infarction (MI) (resting wall motion abnor-
mality, delayed enhancement) were considered positive. On
a 2-day SPECT protocol, both ﬁxed and reversible defects
were apparently considered positive. Combined cardiac MRI
had a sensitivity of 86%, which was signiﬁcantly >67.9% for
SPECT (p < 0.001). Both cardiac MRI and SPECT hada speciﬁcity of 83% (Fig. 4). The greater spatial resolution of
cardiac MRI might explain the improved sensitivity.
SPECT/cardiac MRI/PET. Single-photon emission com-
puted tomography, cardiac MRI, and PET have all been
used for rest/stress perfusion imaging for many years.
Jaarsma et al. (14) performed a meta-analysis of 143 studies
(105 SPECT, 27 cardiac MRI, and 11 PET) published
between 1990 and 2010 in which these modalities were used
to diagnose CAD by invasive angiography. In contrast to the
prospective study by Greenwood et al. (13) (described in the
preceding text), Jaarsma et al. (14) found that the pooled
sensitivity for all 3 modalities were not signiﬁcantly different
from each other (SPECT ¼ 88%, cardiac MRI ¼ 89%,
PET ¼ 84%). However, SPECT had a lower pooled
speciﬁcity (61%) than either cardiac MRI (76%) or
PET (81%).
MI cardiac MRI: prevalence of unrecognized infarction.
Delayed enhancement imaging with cardiac MRI is more
sensitive than electrocardiography (ECG) for detecting MI.
However, previous population studies of the prevalence of
clinically unrecognized MI have used ECG as the reference
standard. Schelbert et al. (15) studied 936 subjects (median
age 76 years, 52% female) as part of a cohort called
ICELAND MI. In that cohort, cardiac MRI delayed
enhancement detected unrecognized MI in 17% of subjects
(95% conﬁdence interval [CI]: 14% to 19%), which was
signiﬁcantly greater than the 5% rate of unrecognized MI
detected by ECG (95% CI: 4% to 6%, p < 0.001).
MI cardiac MRI: T1 mapping. Most cardiac MRI tissue
characterization techniques depend on relative signal
differences and do not give absolute measurements. Over the
Figure 3 FFR Measured Noninvasively From Coronary CTA
Fractional ﬂow reserve measured noninvasively from coronary CTA with computational ﬂuid dynamics in a patient with signiﬁcant-appearing stenosis on CTA. (A) Noncalciﬁed
plaque of interest (red arrow) on CTA; (B) same stenosis as seen on invasive, selective coronary angiography (red arrow). (C) The FFRCT is 0.85. Vessel portions in blue have
the highest FFR, green shading denotes intermediate FFR. (D) The FFR measured invasively was 0.84, conﬁrming lack of hemodynamic signiﬁcance. Reprinted, with permission,
from Koo et al. (12). Abbreviations as in Figure 2.
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2474past several years, there has been interest in measuring the
absolute value of a cardiac MRI tissue property called T1
relaxation time. Dall’Armellina et al. (16) used a 3-T cardiac
MRI scanner in 41 patients with acute MI (32 STEMI) to
measure the utility of T1 mapping for the detection of acute
MI. For each of 674 segments the authors compared the
average T1 value within the segment with cardiac MRI
delayed enhancement. The segmental mean T1 was associ-
ated with (subjective) segmental delayed enhancement
(p < 0.01). In 198 segments with abnormal function, T1
was associated with recovery of function at 6 months
(p < 0.004). The authors concluded that T1 mapping might
be useful in the evaluation of MI.CAD Prognosis
PET. There has been a longstanding interest in use of
stress imaging techniques to improve risk stratiﬁcation.
Murthy et al. (17) examined the value of quantitative
coronary ﬂow reserve (CFR) measurements by PET in
2,783 patients followed for a median of 1.4 years. Patients
with CFR <1.5 had a 5.6-fold increase in cardiac death,
compared with patients with CFR >2.0 (Fig. 5). The CFR
correctly reclassiﬁed 34.8% of intermediate risk patients; the
reclassiﬁcation index in these patients was 0.484.CT: coronary artery calcium. The value of coronary
artery calcium (CAC) scanning for identifying patients for
aggressive, cost-effective pharmacologic risk factor manage-
ment has not been well-deﬁned. Blaha et al. (18) performed
a retrospective analysis of the 6,814 individuals enrolled in
the MESA (Multi-Ethnic Study of Atherosclerosis) (2000
to 2002) and found that 2,083 met the inclusion criteria for
the recent JUPITER (Justiﬁcation for the Use of Statins in
Primary Prevention: An Intervention Trial Evaluating
Rosuvastatin) of high-sensitivity C-reactive protein. These
patients were further stratiﬁed by CAC. After adjustment for
Framingham risk factors, “high” high-sensitivity C-reactive
protein was not predictive of coronary (hazard ratio [HR]:
0.98, 95% CI: 0.62 to 1.57) or cardiovascular (HR: 1.15,
95% CI: 0.78 to 1.68) events over a mean follow-up of 5.8
years. In contrast, after adjustment for Framingham risk
factors, CAC had a HR of 6.65 (95% CI: 2.99 to 14.78) for
coronary events and an HR of 3.06 (95% CI: 1.82 to 5.13)
for cardiovascular events. Reclassiﬁcation data were not
presented. With the event reduction rates from the
JUPITER trial, the predicted number needed to treat to
prevent coronary events over 5 years in patients with calcium
scores of 0, 1 to 100, and >100 were 549, 94, and 24,
respectively; for cardiovascular events, they were 124, 54, and
19, respectively.
Figure 4
ROC Curves of Summed Stress Scores for
CMR and SPECT
Receiver operating characteristic (ROC) curves of summed stress scores for
cardiac magnetic resonance imaging (CMR) and single photon emission computed
tomography (SPECT). LAD ¼ left anterior descending; LCx ¼ left circumﬂex;
LMS ¼ left main stem; RCA ¼ right coronary artery. Modiﬁed, with permission,
from Greenwood et al. (13).
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2475CT: coronary CTA. The number of stenosed coronary
arterial segments on invasive angiography has long been
recognized to predict poor outcome. In the last year, multiple
large studies have been performed to determine whether
similar prognostic information can be obtained from coro-
nary CTA (Table 2). In particular, the CONFIRM registryFigure 5 Kaplan-Meier Plot of Cardiac Mortality
Kaplan-Meier plot of cardiac mortality (A) and after adjustment for age, sex, body mass ind
artery disease, chest pain, dyspnea, early revascularization, last ejection fraction, summ
between coronary ﬂow reserve and cardiac mortality. HR ¼ hazard ratio. Reprinted, with(19) included 27,125 consecutive patients that were used in
3 of the papers cited in the table.
Cardiac MRI: acute MI. Recent cardiac MRI studies have
shown that right ventricular (RV) infarction and/or edema
occurs in 51% of STEMI patients (20). Grothoff et al. (21)
performed cardiac MRI to assess the RV in 450 patients 1 to
4 days after primary angioplasty for STEMI. Patients were
followed for an average of 21 months for a composite
endpoint of death, reinfarction, and new congestive heart
failure. The authors deﬁned RV injury as a combination of
edema and associated wall motion impairment. An RV
injury was independently associated with adverse events
(HR: 3.36, p < 0.001) in a multivariate model that included
left ventricular ejection fraction (LVEF) and Thrombosis In
Myocardial Infarction risk score.
Chronic CAD: Patient Management
SPECT. Shaw et al. (22) reported on the WOMEN
(What Is the Optimal Method for Ischemia Evaluation in
Women) Trial, a randomized trial comparing SPECT and
exercise treadmill testing (ETT) in the evaluation of
symptomatic low- or intermediate-risk women with sus-
pected CAD, an interpretable ECG, and the ability to
exercise (Table 3). Two-year survival free of major adverse
cardiac events was similar in the 2 groups (98.0% for ETT,
and 97.7% for SPECT, p ¼ 0.59) (Fig. 6). There was no
difference in the percentage of women who were angina-free
during follow-up between the 2 strategies. Most impor-
tantly, the cumulative diagnostic cost savings for ETT
compared with SPECT was 48%.
In a separate report, Shaw et al. (23) reported a post hoc
substudy from the COURAGE (Clinical OutcomesUtilizing
Revascularization and Aggressive Drug Evaluation) trial that
examined the impact of baseline stress SPECT ischemia (asex, hypertension, hyperlipidemia, diabetes, family history, tobacco use, prior coronary
ed stress score, and ejection fraction reserve, (B) showing a signiﬁcant association
permission, from Murthy et al. (17).
Table 2 Coronary CTA Prognosis Studies With >1,000 Patients
First Author
(Ref. #) n Setting
Number
of CT
Detector
Rows Outcome Follow-Up
Annual Event
Rate for Patients
With Normal
Coronary Arteries Multivariate Model Multivariate Result Reclassiﬁcation Analysis
Andreini (44) 1,196 Single center 64 SD Cardiac death
or nonfatal MI
4.3  1.8 yrs No events Framingham risk
score, anti-anginal
medication, statin,
aspirin
1-vessel CAD or greater by
coronary CTA associated
with increased event rate
(HR: 8.76 for 1 vessel CAD,
p <0.001)
Not performed
Min (45) 23,854 CONFIRM 64 SD,
64 DD,
128 DD
All-cause
mortality
2.3  1.1 yrs 0.28% Age, clinical risk
factors
1-vessel CAD or greater by
coronary CTA associated
with increased all-cause
mortality (HR: 2.35 for 1
vessel CAD, p <0.001)
Not performed
Chow (46) 13,966 CONFIRM 64 SD,
64 DD,
128 DD
All-cause
mortality
1.9  0.0 yrs 0.4% NCEP/ATP III risk,
LVEF
Non-obstructive CAD* or
greater by coronary CTA
associated with increased
all-cause mortality (HR ¼
2.57 for non-obstructive),
NRI ¼ 17.8%, p < 0.001
Villines (47) 10,037 CONFIRM 64 SD,
64 DD,
128 DD
All-cause
mortality
2.1 yrs,
IQR ¼ 2.0 yrs
0.27% Not performed for
all-cause mortality
endpoint
NA Among patients with coronary
calcium score of zero, CAD
was not associated with
increased all-cause
mortality
Lin (48) 2,583 patients
with <50%
stenosis by
coronary CTA
2 centers 64 SD All-cause
mortality
3.1  0.5 yrs 0.34% Framingham risk
score
Presence of any, non-
obstructive plaque
associated with increased
all-cause mortality (HR:
2.74, p ¼ 0.003)
NRI ¼ 20.5%, p ¼ 004
Yiu (49) 2,432 4 centers 320 SD,
64 SD,
Cardiac death
or nonfatal MI
2.2 yrs
(25–75th
percentile:
1.3–3.1 yrs)
0.07% for men,
0.2% for women
Not performed NA CTA predictive of events in
patients 60 yrs of age and
in men <60 (p <0.01 for
all) but not in women <60
yrs of age (p < 0.45)
*<50%. Reprinted, with permission, from Shreibati JB et al. (27).
CAD ¼ coronary artery disease; CONFIRM ¼ coronary computed tomography angiography evaluation for clinical outcomes registry; CTA ¼ computed tomography angiography; DD ¼ dual detector; HR ¼ hazard ratio (note that the reported HRs are for single vessel coronary
disease); IQR ¼ interquartile range; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; NCEP/ATP III ¼ National Cholesterol Education Program/Adult Treatment Panel III; NRI ¼ net reclassiﬁcation index (for Chow the comparison was of CAD þ LVEF model
compared with a model containing clinical predictors and LVEF; for LIN the comparison was of CAD compared with Framingham risk); SD ¼ single detector.
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Table 3 Selected Studies of Clinical/Economic Impact of Noninvasive Testing for CAD
First Author (Ref. #) N Modality Endpoint Results
Shaw (22) 824 SPECT vs. ETT Death/MI/adm.
Angina-free
Diagnostic costs
2.3% at 2 yrs vs. 1.7% at 2 yrs, p ¼ 0.59
64.9% at 2 yrs vs. 60.4% at 2 yrs, p ¼ 0.58
$492.67 (median) vs. $174.14 (median), p ¼ 0.001
Hachamovitch (24) 1,703 SPECT, PET, CTA Referral to cath
Aspirin
Lipid-lowering
Cath after mod/sev abn >Cath after mild abn >Cath after nl
Cath after CTA >cath after SPECT or PET for nl or mildly abn
Increased from 58% to 76% after mod/sev abn study
Increased from 63% to 77% after mod/sev abn study
Tandon (25) 2,442 CTA vs. SPECT Referral to cath
Referral to revasc.
Similar for CTA (10.6%) and SPECT (10.2%)
Similar for CTA (6.2%) and SPECT (5.9%)
McEvoy (50) 2,000 CTA vs. no CTA Aspirin use at 18 months
Statin use at 18 months
Referral to revasc.
26% for CTA abn vs. 3% for CTA nl vs. 6% for no CTA
20% for CTA abn vs. 3% for CTA nl vs. 6% for no CTA
1% for CTA vs. 0.1% for no CTA, p < .001
Pazhenkottil (26) 318 CTA and SPECT
Matched stenosis vs.
unmatched stenosis vs. nl
Referral to revasc. 41% in matched vs. 11% in unmatched vs. 0% in nl,
p < 0.0001
Shreibati (27) 282,830 CTA vs. SPECT Referral to cath
PCI
CABG
Healthcare spending
Greater with CTA AOR: 2.19 (95% CI: 2.08–2.32), p < 0.001
Greater with CTA AOR: 2.49 (95% CI: 2.28–2.72), p < 0.001
Greater with CTA AOR: 3.00 (95% CI: 2.63–3.41) p < 0.001
Greater with CTA: $4,200 (3,193–5,267), p < 0.001
Abn ¼ abnormal; AOR ¼ adjusted odds ratio; CABG ¼ coronary artery bypass grafting surgery; cath ¼ cardiac catheterization; CI ¼ conﬁdence interval; ETT ¼ exercise treadmill test; Mod ¼moderately; nl ¼
normal; PCI ¼ percutaneous coronary intervention; PET ¼ cardiac positron emission tomography; Revasc ¼ revascularization (PCI or CABG); Sev ¼ severity; SPECT ¼ single-photon emission computed
tomography; other abbreviations as in Table 2.
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2477assessed by site investigators) on the effectiveness of optimal
medical therapy and PCI with optimal medical therapy alone.
Surprisingly, the extent of ischemia did not predict adverse
events or alter treatment effectiveness, contrary to both prior
observational studies and a prior analysis with quantitative
core laboratory methods in a different COURAGE cohort.
SPECT/PET/CTA. Hachamovitch et al. (24) reported
the results of the large multicenter prospective registry, the
SPARC study (Study of Perfusion and Anatomy’s Role in
Coronary Artery Disease). They assessed 90-day post-test
rates of invasive angiography and medication changes in
565 patients studied by SPECT, 548 patients studied by
PET, and 590 patients studied by coronary CTA.Figure 6
Kaplan-Meier Plot Showing Major Adverse
Cardiovascular Event-Free Survival
Kaplan-Meier plot showing major adverse cardiovascular event-free survival,
according to initial randomized assignment to exercise treadmill test (ETT) or
exercise myocardial perfusion imaging by single photon emission computed
tomography (MPI). Reprinted, with permission, from Shaw et al. (22).Surprisingly, in patients with the most severely abnormal
tests, 38% to 61% were not referred to invasive angiography,
20% to 30% were not receiving aspirin 90 days after the
baseline test, 35% to 40% were not receiving a beta-blocker,
and 20% to 25% were not receiving a lipid-lowering agent.
Changes in medication and referral to invasive angiography
were far less frequent than expected after moderately or
severely abnormal studies (Fig. 7). Compared with SPECT
and PET, CTA was associated with more changes in aspirin
and lipid-lowering agent use and higher 90-day rates of
referral to invasive angiography after normal, nonobstructive,
or mildly abnormal test results.Figure 7 Post-Test Changes in Patient Management
Frequency of referral for cardiac catheterization (Cath), medication (Med) change,
both, or neither within 90 days after cardiac imaging. Within each test result,
chi-square tests of association are shown. Even when tests were moderately or
severely abnormal, approximately one-half of the patients did not undergo cardiac
Cath or Med change; one-quarter did not undergo either. Reprinted, with
permission, from Hachamovitch et al. (24).
Table 4
Adjusted Association Between Noninvasive Cardiac Testing and 180-Day Spending in
282,830 Fee-for-Service Medicare Beneﬁciaries
SPECT CTA Stress Echo ETT
Adjusted Spending 24,136 28,336 19,156 16,687
Difference 0 þ4,200 4,981 7,449
(95% CI), $ (Reference) (3,193 to 5,267) (4,991 to 4,969) (7,452 to 7,444)
p (multivariable model) <0.001 <0.001 <0.001
Years 2006 to 2008. Modiﬁed, with permission, from Shreibati JB et al. (27).
Echo ¼ echocardiogram; other abbreviations as in Tables 2 and 3.
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2478SPECT/CTA. Several studies examined the impact of
SPECT and coronary CTA on patient management.
Tandon et al. (25) compared 1,221 patients evaluated with
coronary CTA with 1,221 matched patients evaluated by
SPECT. Referral to invasive angiography was similar in
both groups (10.6% for coronary CTA; and 10.2% for
SPECT). Rates of revascularization were also similar.
Coronary CTA had a lower false positive rate than SPECT
(9.7% vs. 25.8%, p ¼ 0.009). Pazhenkottil et al. (26)
examined the impact of hybrid imaging with SPECT and
coronary CTA in 318 consecutive patients. Referral to
revascularization was higher in patients with matched
abnormalities (41%), compared with those with unmatched
abnormalities (11%) or those with normal studies (0%).
Shreibati et al. (27) examined subsequent noninvasive
testing and costs after SPECT, coronary CTA, stress
echocardiography, and ETT in 282,830 fee-for-service
Medicare beneﬁciaries. Compared with SPECT, coronary
CTA was more often followed by cardiac catheterization
(adjusted odds ratio [OR]: 2.19), PCI (adjusted OR: 2.49),Table 5 Randomized Trials of Chest Pain Triage in the ED
First Author
(Ref. #) n Pts Random MACE Diff.
Farkouh (51) 424 IR CPU vs. Adm 6 months NS
Udelson (52) 2,475 ACS SPECT vs. UC 30 days NS
Goldstein (53) 197 CP CTA vs. SPECT 6 months NS
Goldstein (54) 699 LR CTA vs. SPECT 6 months NS
Litt (55) 1,370 LIR CTA vs. UC 30 days NS
Hoffmann (56) 1,000 ACS CTA vs. UC 28 days NS
Miller (57) 109 IR MR vs. Adm 12 months NS
Miller (58) 120 LR MR vs. MD 30 days NS
ACS ¼ acute coronary syndrome; Adm ¼ admission; CP ¼ chest pain; CPU ¼ chest pain unit; d ¼ days
coronary angiography; IR ¼ intermediate risk; LR ¼ low risk; MD ¼ physician choice for testing; mo ¼ m
randomization; Random ¼ randomization; UC ¼ usual care; w/o ¼ without; Y ¼ yes.and coronary artery bypass surgery (adjusted OR: 3.0). This
led to higher total healthcare spending (Table 4). In
contrast, compared with SPECT, both stress echocardiog-
raphy and ETT were associated with lower healthcare
spending (Table 4).
SPECT/cardiac MRI. Van der Veen et al. (28) demon-
strated the feasibility of an automated software tool using
geometrical algorithms to quantify ventricular dyssynchrony
with gated SPECT in 24 heart failure patients with proven
dyssynchrony by cardiac MRI and compared the results with
a normal population of 80 patients. Several parameters
demonstrated highly signiﬁcant differences between the
normal and abnormal populations.
Acute CAD: Patient Management
Chest pain triage in the emergency room remains a major
challenge. Several randomized trials in the past year have
evaluated coronary CTA and cardiac MRI. Table 5
compares them with the previous randomized trials on thisAdmissions Cost
ED Time ResultsH CPU ED Total
R R N Y N Lower adm rate and total
costs with CPU
Y Y N N Y Lower adm rate with
SPECT in pts w/o
ischemia
Y E Y N Y Lower ED costs with CTA
ICA only E Y N DX only Lower ED costs with CT;
shorter DX time with
CTA
Combined N N Y Lower rate of H/CPU
adm, shorter ED time
with CTA
Y Y N Y Y Shorter stay, fewer adm
with CTA
No difference in total
costs
R R N Y N Lower adm rate and total
costs with MR
Y E Y N Y No diff. in ED time with
MR
ED costs higher with MR
Very low adm rate in both
groups
; Dx ¼ diagnostic; E ¼ required for enrollment; ED ¼ Emergency Department; H ¼ hospital; ICA ¼
onths; MR ¼ stress cardiac magnetic resonance imaging; N ¼ no; Pts ¼ patients; R ¼ required by
Figure 8 CT Angiography of Heart, Aortic Root, and Ascending Aorta
Computed tomography (CT) angiography of heart, aortic root and ascending aorta, reformatted in oblique-sagittal (A) and oblique-coronal (B) planes. Diameter measurements
are taken at the sinotubular junction (*), the aortic annulus (y), and the left ventricular outﬂow tract (z). Reprinted, with permission, from Jabbour et al. (33).
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2479subject. Gibbons (29) highlighted the strengths and weak-
nesses of the trials of coronary CTA. Prasad et al. (30) called
for randomized trials to determine whether any testing is
justiﬁed in low-risk patients.Table 6 Cardiovascular CT Imaging Before TAVI
First Author
(Ref. #)
Imaging
Techniques n Outcomes Variables
Tamborini (32) 3D TEE
64-detector
row CT
122 LCC length
LM-AA distance (pre-op)
Min-D and Max-D, aortic
annulus
LCC len
LM-AA d
0.001
Min-D: 2
Max-D:
Jabbour (33) Cardiac MRI
128-detector
row dual
source CT
TTE
202 Largest diameter
Aortic valve annulus
Sinus of Valsalva
Sinotubular junction
Ascending aorta
Bias (m
Aortic v
Sinus o
Sinotub
Ascendi
Bias (m
Aortic v
Sinus o
Sinotub
Ascendi
Bias (m
Aortic v
Sinus o
Sinotub
Ascendi
Willson (59) 64-detector
row CT
109 Difference between
prosthesis size and
annular size
measured by CT
Presence and severity of
post-procedural PAR
Modera
sizing
for tr
Differen
predi
circum
Studies >100 patients.
AR ¼ aortic regurgitation; AUC ¼ area under the curve; CT ¼ computed tomography; LCC ¼ left corona
minimal diameter; MRI¼magnetic resonance imaging; PAR¼ paravalvular aortic regurgitation; pre-op ¼
echocardiography; TTE ¼ transthoracic echocardiogram; 3D ¼ 3-dimensional.Structural Heart Disease
PET/CT. Sarrazin et al. (31) reported on the use of FDG
PET/CT imaging in patients with suspected infections ofMajor Findings Comments
gth: 13.7  1.8 vs. 13.6  1.8 (r ¼ 0.69, p < 0.001)
istance: 13.5  2.2 vs. 13.9  2.2 (r ¼ 0.83; p <
)
3.3  2.1 vs. 21.4  2.2 (r ¼ 0.70; p < 0.001)
24.6  2.3 vs. 25.3  2.2 (r ¼ 0.68, p < 0.001)
m) cardiac MRI vs. CT
alve annulus: 0.39  2.54
f Valsalva: 0.24  2.25
ular junction: 0.81  2.01
ng aorta: 0.1  2.21
m) cardiac MRI vs. TTE
alve annulus: 4.52  3.29
f Valsalva: 0.45  3.45
ular junction: 0.73  3.94
ng aorta: 1.78  4.21
m) CT vs. TTE
alve annulus: 4.1  3.25
f Valsalva 0.33  3.43
ular junction: 0.06  4.6
ng aorta: 1.56  4.04
Presence and severity of
AR after TAVI were
associated with larger
aortic annulus
measurements by
both cardiac MRI and
CT but not TTE
te to severe PAR in 13/102 pts associated with under-
of prosthesis (0.7  1.4 mm vs. a 0.9  1.8 mm)
ivial to mild PAR
ce between prosthesis size and annular size by CT
ctive of PAR (AUCs: mean diameter, 0.81; area, 0.8;
ference, 0.76)
ry cusp; LM-AA ¼ left main coronary ostium to aortic annulus; Max-D ¼ maximal diameter; Min-D ¼
pre-operative; pts ¼ patients; TAVI ¼ transcatheter aortic valve implantation; TEE¼ transesophageal
Figure 9
Kaplan-Meier Analysis of 143 Patients With
Aortic Stenosis
Kaplan-Meier analysis of 143 patients with aortic stenosis shows a signiﬁcant
increase in cardiac mortality with midwall ﬁbrosis (orange dashed line) or
infarction (green solid line) compared with the no late enhancement (LGE) group
(blue dotted lines). Modiﬁed, with permission, from Dweck et al. (35).
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2480implantable devices (ID) (i.e., pacemakers and implantable
cardioverter-deﬁbrillators). They compared FDG uptake in
42 patients with suspected ID infection with 24 patients
with ID without infection (12 with recent IDs, 12 with
older IDs). Of the 42 patients, 32 had positive FDG scans;
24 underwent extraction, and 6 patients were treated as
superﬁcial infection with clinical improvement. Ten patients
with negative scans were treated with antibiotics only
without recurrence. Patients with ID without infection had
either no FDG uptake or mild uptake at the level of the
connector.
CT transcatheter aortic valve implantation: planning.
The success of transcatheter aortic valve implantationFigure 10 CT Characteristics of Culprit Lesion in a Patient With Pos
Coronary computed tomography (CT) angiography plaque imaging in a patient who had ca
coronary intervention (PCI) of a high-grade distal right coronary artery stenosis (arrow). (A
coronary artery. Cross sectional reformations in (C) a proximal reference segment, (D) a
(remodeling index: 1.28), spotty calciﬁcation (D) (red circle), and low CT density (16 Hodepends on various patient-related factors (Fig. 8).
Table 6 summarizes studies that examined the value of
cardiac CT compared with other imaging modalities for
optimizing and predicting the outcome of transcatheter
aortic valve implantation in more than 100 patients
(32,33). The aortic annular dimensions are larger when
measured by cardiac CT rather than by echocardiography.
Sizing aortic valve prostheses on the basis of echocardio-
graphic measurements alone is associated with a higher
prevalence and severity of post-procedural paravalvular
aortic regurgitation.
Cardiac MRI: aortic stenosis. In aortic stenosis, cardiac
MRI might also be used to detect a midwall pattern of
myocardial ﬁbrosis (34). This pattern is distinct from the
ﬁbrosis seen in MI from CAD. However, it is not known
whether midwall ﬁbrosis portends poor prognosis. Dweck
et al. (35) studied 143 patients with moderate or severe
aortic stenosis who underwent gadolinium-enhanced car-
diac MRI for evaluation of delayed enhancement. Patients
were followed for 2.0  1.4 years for all-cause mortality.
Midwall ﬁbrosis was independently associated with
increased all-cause mortality (HR: 5.35, p ¼ 0.03) after
adjustment for LVEF, infarct-pattern ﬁbrosis, and subse-
quent aortic valve replacement. Kaplan-Meier survival
estimates showed a signiﬁcant increase in cardiac mortality
in both the midwall ﬁbrosis and the infarct groups (Fig. 9),
although at 4 years the number of patients in each group
was small. Midwall ﬁbrosis seems to be an independent
prognostic marker in patients with aortic stenosis.
Cardiac MRI. In hypertrophic cardiomyopathy some
studies have found that myocardial ﬁbrosis, as measured with
delayed-enhancement cardiac MRI is associated with cardiac
death, but others have not. These studies have generallyt-PCI in a TnT Elevation 3 Upper Limit of Normal
rdiac troponin elevation 3 upper limit of normal after percutaneous
) Selective coronary angiogram. (B) Multi-planar reconstruction of the right
t the stenosis, and (E) a distal reference segment show positive remodeling
unsﬁeld units). Reprinted, with permission, from Watabe et al. (41).
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2481been underpowered for outcomes. Therefore, the presence of
delayed enhancement is currently only recommended for
“resolving clinical decision making” when risk stratiﬁcation
“is inconclusive after documentation of the conventional risk
factors” (36). Green et al. (37) performed a meta-analysis of
4 single-center studies. Pooled together, the 4 studies
included 1,063 patients followed an average of 3.1 years with
36 cardiac deaths. In their analysis, delayed enhancement was
associated with cardiac death (pooled OR: 2.92, p¼ 0.0047).
However, because no multivariate analysis was performed, it
is not clear whether delayed enhancement adds prognostic
information that is incremental to clinical risk factors.
Cardiac MRI can risk-stratify patients undergoing cardiac
resynchronization therapy (CRT), by using delayed en-
hancement imaging as a marker for poor response to CRT
and/or poor overall prognosis. Leyva et al. (38) studied 97
patients with dilated cardiomyopathy and 161 patients with
ischemic cardiomyopathy undergoing CRT. Patients
underwent a cardiac MRI examination before CRT place-
ment and then follow-up for up to 8.7 years. Among the
patients with dilated cardiomyopathy, those with midwall
ﬁbrosis had increased cardiovascular mortality, even after
accounting for New York Heart Association functional class,
QRS duration, and LVEF (p ¼ 0.008). Patients with dilated
cardiomyopathy and midwall delayed enhancement had
a similarly poor prognosis as patients with ischemic
cardiomyopathy, but patients with dilated cardiomyopathy
and no delayed enhancement had a much better outcome.
By measuring a cardiac MRI property know as TI before
and after administration of intravenous contrast material,
extracellular volume can be calculated. Wong et al. (39) used
this technique in 793 patients and followed them for a mean
of 0.8 years. Extracellular volume fraction was associated
with all-cause mortality, even after accounting for LVEF,
MI size, and patient age.Vascular Structure
CT: plaque imaging. Efforts continue to deﬁne the clinical
implications of plaque composition by coronary CTA.
Ozaki et al. (40) compared the coronary CTA charac-
teristics of 75 culprit lesions in 75 patients with chest pain
and acute coronary syndromes or stable angina with the
presence of intra-luminal thrombus assessed on optical
coherence tomography or angioscopy and integrity of the
ﬁbrous cap on optical coherence tomography. On coronary
CTA, low attenuation plaques were more frequently
observed in acute coronary syndromes with ruptured ﬁbrous
caps than with intact ﬁbrous caps (88% vs. 58%). Positive
remodeling was more frequent in lesions with ruptured
ﬁbrous caps than with intact ﬁbrous caps (96% vs. 34%).
However, coronary CTA could not clearly distinguish
between lesions with intact ﬁbrous caps that had thrombus
and those that did not.
Watabe et al. (41) studied 107 patients scheduled to
undergo elective PCI for stable angina with coronary CTAto predict post-procedural cardiac troponin T elevations
(cTnT). In patients who had cTnT elevation 3 the upper
limit of normal, compared with patients who did not have
signiﬁcant post-procedural cTnT elevations (Fig. 10), the
attenuation value of the culprit plaque was signiﬁcantly lower
(43.0 [26.5 to 75.7] Hounsﬁeld units vs. 94.0 [65.0 to
109.0] Hounsﬁeld units), the remodeling index was signif-
icantly greater (1.20  0.18 vs. 1.04  0.15), and spotty
calciﬁcation was signiﬁcantly more frequent (50% vs. 11%)
(p < 0.001 for all comparisons) (Fig. 10). Positive remod-
eling and spotty calciﬁcation were independent predictors
for cTnT elevation in multivariate analysis. Plaque attenu-
ation value, remodeling index, and spotty calciﬁcation taken
together had a positive predictive value of 94% and an NPV
of 90% for post-procedural cTnT elevation 3 the upper
limit of normal.
Appropriateness
Shah et al. (42) used an administrative database to study the
incidence of stress imaging (SPECT and echocardiography)
exams within 1 month of a cardiac outpatient visit after
revascularization. The cumulative incidence was 12.2%
within 30 days. The adjusted ORs among patients treated
by physicians who billed for both technical and profes-
sional fees, compared with patients treated by physicians
who did not bill for either, was 2.3 (95% CI: 1.8 to 2.9)
for SPECT and 12.8 (95% CI: 7.6 to 21.6) for echocardi-
ography. These data strongly suggest that ﬁnancial incen-
tives inﬂuence the decision to perform stress imaging after
coronary revascularization.
The American College of Radiology published appro-
priateness criteria for patients with chronic chest pain and
a high probability of CAD (43).
Conclusions
We hope that this review will inspire readers to examine the
individual publications in more detail.Reprint requests and correspondence: Dr. Raymond J. Gibbons,
Mayo Clinic, Gonda 6, 200 First Street Southwest, Rochester,
Minnesota 55905. E-mail: gibbons.raymond@mayo.edu.
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